Welcome to MutualFunds.com. Please help us personalize your experience.
Thank you for your submission, we hope you enjoy your experience

Select the one that best describes you
Mutualfunds logo

PHSBX Putnam Global Health Care B

  • Fund
  • PHSBX
  • Price as of: Aug 08, 2016
  • $41.16
  • - $0.48
  • - 1.15%
  • Category
  • Health & Biotech Equities

PHSBX - Profile

Vitals

  • YTD Return -4.9%
  • 3 Yr Annualized Return 12.7%
  • 5 Yr Annualized Return 15.1%
  • Net Assets $1.57 B
  • Holdings in Top 10 40.7%

52 WEEK LOW AND HIGH

$41.16
$36.32
$51.88

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.85%

SALES FEES

  • Front Load N/A
  • Deferred Load 5.00%

BROKERAGE FEES

  • Turnover 20.00%

TRADING FEES

  • Max Redemption Fee 1.00%

Min Investment

STANDARD (TAXABLE)

$0

IRA

N/A

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return -4.9%
  • 3 Yr Annualized Total Return 11.9%
  • 5 Yr Annualized Total Return 14.9%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.58%
DIVIDENDS
  • Dividend Yield 0.8%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Putnam Global Health Care Fund
  • Fund Family Name Putnam
  • Inception Date Mar 01, 1993
  • Shares Outstanding N/A
  • Share Class B
  • Currency USD
  • Domiciled Country United States
  • Manager Isabel Buccellati

Fund Description

The fund invests mainly in common stocks (growth or value stocks or both) of large and midsize companies worldwide that the manager believes have favorable investment potential. Under normal circumstances, it invests at least 80% of its net assets in securities of companies in the health care industries. The fund is non-diversified.

PHSBX - Performance

Return Ranking - Trailing

Period PHSBX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -4.9% -25.2% 18.9% 67.86% 4
1 Yr -12.2% -29.1% 15.0% 62.50% 4
3 Yr 12.7% * 4.7% 22.2% 66.97% 4
5 Yr 15.1% * 10.5% 23.7% 78.10% 4
10 Yr 8.5% * 8.3% 16.3% 96.04% 5

* Annualized


Return Ranking - Calendar

Period PHSBX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -10.2% -20.4% 13.8% 86.24% 5
2014 N/A 13.1% 21.8% N/A N/A
2013 N/A 30.6% 65.2% N/A N/A
2012 N/A 9.6% 27.7% N/A N/A
2011 N/A -1.8% 18.0% N/A N/A

Total Return Ranking - Trailing

Period PHSBX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -4.9% -25.2% 18.9% 67.86% 4
1 Yr -15.9% -32.7% 15.0% 71.43% 4
3 Yr 11.9% * 3.2% 22.2% 65.14% 4
5 Yr 14.9% * 9.9% 23.7% 75.24% 4
10 Yr 8.5% * 8.0% 16.3% 94.06% 5

* Annualized


Total Return Ranking - Calendar

Period PHSBX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -10.2% -20.4% 13.8% 86.24% 5
2014 N/A 17.6% 22.2% N/A N/A
2013 N/A 51.1% 71.1% N/A N/A
2012 N/A 19.8% 39.6% N/A N/A
2011 N/A 13.8% 20.1% N/A N/A

NAV & Total Return History

PHSBX - Holdings

Filings data as of: Jun 30, 2016

Concentration Analysis

PHSBX Category Low Category High PHSBX % Rank Quintile
Net Assets 1.57 B 23.8 M 50.7 B 16.07% 3
Number of Holdings 117 30 356 8.93% 1
Net Assets in Top 10 618 M 9.08 M 20.2 B 16.07% 3
Weighting of Top 10 40.7% 22.2% 68.4% 21.43% 3

Top 10 Holdings

  1. Gilead Sciences Inc 5.68%
  2. Allergan PLC 6.48%
  3. Celgene Corp 5.11%
  4. Sanofi SA 2.96%
  5. Eli Lilly and Co 3.19%
  6. Bristol-Myers Squibb Company 4.00%
  7. Amgen Inc 3.62%
  8. Johnson & Johnson 3.51%
  9. Merck & Co Inc 3.08%
  10. Novartis AG 3.07%

Asset Allocation

Weighting Category Low Category High PHSBX % Rank Quintile
Stocks
97.35% 87.51% 106.76% 22.32% 4
Other
1.39% -6.76% 2.31% 5.36% 2
Cash
1.26% 0.00% 12.50% 16.07% 3
Convertible Bonds
0.00% 0.00% 0.33% 3.57% 2
Preferred Stocks
0.00% 0.00% 1.48% 4.46% 3
Bonds
0.00% 0.00% 1.19% 3.57% 2

Stock Sector Breakdown

Weighting Category Low Category High PHSBX % Rank Quintile
Healthcare
96.39% 14.93% 99.47% 9.82% 2
Consumer Defense
0.70% 0.00% 2.38% 7.14% 1
Industrials
0.26% 0.00% 12.74% 11.61% 2
Financial Services
0.00% 0.00% 1.13% 6.25% 3
Technology
0.00% 0.00% 64.47% 24.11% 5
Real Estate
0.00% 0.00% 1.99% 1.79% 2
Energy
0.00% 0.00% 0.00% 0.89% 2
Communication Services
0.00% 0.00% 2.23% 1.79% 2
Utilities
0.00% 0.00% 1.25% 1.79% 2
Consumer Cyclical
0.00% 0.00% 4.23% 6.25% 3
Basic Materials
0.00% 0.00% 2.05% 3.57% 2

Stock Geographic Breakdown

Weighting Category Low Category High PHSBX % Rank Quintile
US
76.10% 62.67% 99.85% 29.46% 5
Non US
21.25% 0.14% 44.09% 4.46% 1

PHSBX - Expenses

Operational Fees

PHSBX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.85% 0.10% 4.31% 17.86% 4
Management Fee 0.62% 0.08% 1.25% 14.29% 2
12b-1 Fee 1.00% 0.00% 1.00% 1.28% 4
Administrative Fee N/A 0.01% 0.40% N/A N/A

Sales Fees

PHSBX Fees (% of AUM) Category Low Category High PHSBX Rank Quintile
Front Load N/A 3.50% 5.75% N/A N/A
Deferred Load 5.00% 1.00% 5.00% 3.13% 4

Trading Fees

PHSBX Fees (% of AUM) Category Low Category High PHSBX Rank Quintile
Max Redemption Fee 1.00% 0.75% 2.00% 4.55% 3

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

PHSBX Fees (% of AUM) Category Low Category High PHSBX Rank Quintile
Turnover 20.00% 4.00% 249.00% 21.43% 1

PHSBX - Distributions

Dividend Yield Analysis

PHSBX Category Low Category High PHSBX % Rank Quintile
Dividend Yield 0.8% 0.01% 0.94% 6.38% 1

Dividend Distribution Analysis

PHSBX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

PHSBX Category Low Category High PHSBX % Rank Quintile
Net Income Ratio -0.58% -2.26% 1.24% 42.86% 3

Capital Gain Distribution Analysis

PHSBX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

PHSBX - Managers

Isabel Buccellati

Manager

Start Date

Sep 30, 2012

Tenure

3.84

Tenure Rank

13.7%

Ms. Buccellati is an Analyst in the Global Equity Research group at Putnam, covering the health-care sector ex-U.S. She is responsible for conducting fundamental analysis and valuation of the companies in this industry and making buy/sell recommendations. She is also a Portfolio Manager of Putnam Global Health Care Fund and Putnam Global Sector Fund. Prior joined Putnam in 2012, Ms. Buccellati worked for Alliance Growth Equities, a unit of Alliance Bernstein Ltd from 2002 to 2012. Ms. Buccellati has been in the investment industry since 1994.


Kelsey Chen

Manager

Start Date

Jan 31, 2005

Tenure

11.5

Tenure Rank

6.2%

Dr. Chen is an Analyst in the Global Equity Research group, focusing on the U.S. health-care sector. She is responsible for conducting fundamental analysis and valuation of the companies in this industry, and making buy/sell recommendations. In addition, she is a portfolio manager of Putnam Global Health Care Fund, Putnam Global Sector Fund, and Putnam Research Fund. Dr. Chen joined Putnam in 2000 and has been in the investment industry since 1999. Prior to joining Putnam, she was a Summer Associate at Salomon Smith Barney in 1999 and a Project Manager at the University of Texas Medical School in 1998. Dr. Chen earned a Ph.D. from the University of Texas Medical Branch at Galveston, an M.B.A. from the University of Pennsylvania Wharton School, and a B.S. from Wuhan University.


Samuel Cox

Manager

Start Date

Jun 07, 2016

Tenure

0.15

Tenure Rank

22.9%

Putnam Management Analyst : 2014–Present Fidelity Institutional Equity Analyst Management (f/k/a Pyramis Global Advisors) : 2010–2014


Tenure Analysis

Category Low

0.1

Category High

18.9

Category Average

8.99

Category Mode

1.6